News UK trial will see if data trumps hype over ivermectin's role... Despite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a treatment for COVID-19.
News Lilly strikes $1.9bn kidney disease alliance with Ascidian In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.